Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might ...

The downgrade reflects the company’s challenging operating environment in both its Americas and International segments, which saw decreases of 12% and 4.4% respectively. Despite growth in ACCO ...

ACCO Brands (NYSE:ACCO – Get Free Report) had its price target lowered by investment analysts at Barrington Research from $7.50 to $7.00 in a report issued on Tuesday,Benzinga reports. The firm ...

Acco shares have climbed 5% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.52, a decline of 14% in the last 12 months. This story was generated by ...

On a per-share basis, the Lake Zurich, Illinois-based company said it had net income of 21 cents. Earnings, adjusted for amortization costs and restructuring costs, were 39 cents per share.

Terns Pharmaceuticals is a small-cap biotech with a couple of weight loss candidates in its pipeline. The stock's price ...

ACCO Brands Corporation (NYSE ... time we issued our fourth quarter outlook to the end of the year resulted in $12 million of lower sales and $0.02 of lower EPS. In the fourth quarter, the overall ...

Mid-stage data from its two weight loss candidates could be major catalysts that send its share price soaring, but Terns might not even provide updates on these products in the next 12 months.